2014 Annual Meeting | 3MS.001 - Small Fiber Neuropathies: Sensory, Autonomic and Both

Date Monday 04/28/14

Time 06:30 AM - 08:00 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Morning Seminar

Director(s) Roy L. Freeman, MD

Topic(s)

Learning Objectives Participants should be familiar with the pathophysiology, semiology, differential diagnosis, small fiber and autonomic testing, laboratory evaluation, and treatment of small fiber somatic and autonomic neuropathies.

CME Available No CME available

Recommended Audience General Neurologist, Specialist Neurologist

Teaching Styles Didactic

Event Timeline
06:30 AM - 06:45 AM		Introduction Roy L. Freeman, MD
06:45 AM - 07:15 AM		Small Fiber Neuropathy - Sensory Christopher H. Gibbons, MD, FAAN
07:15 AM - 08:00 AM		Small Fiber Neuropathy - Autonomic Roy L. Freeman, MD

Faculty Disclosures
Roy L. Freeman, MD	Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regenacy. Dr. Freeman has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurobo. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli-Lilly. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Inhibikase. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Freeman has stock in Neurobo. Dr. Freeman has stock in Cutaneous NeuroDiagnostics. The institution of Dr. Freeman has received research support from NIH. The institution of Dr. Freeman has received research support from Theravance. The institution of Dr. Freeman has received research support from Biohaven. The institution of Dr. Freeman has received research support from Lundbeck.
Christopher H. Gibbons, MD, FAAN	Dr. Gibbons has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience. Dr. Gibbons has stock in CND Life Sciences. Dr. Gibbons has received publishing royalties from a publication relating to health care. Dr. Gibbons has received personal compensation in the range of $5,000-$9,999 for serving as a Expert Advisor with Department of Justice.